{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:22Z","timestamp":1761129502859},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.cpet.2017.11.007","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T22:36:02Z","timestamp":1519425362000},"page":"225-237","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Role of PET Imaging in Gynecologic Radiation Oncology"],"prefix":"10.1016","volume":"13","author":[{"given":"Yuan James","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perry W.","family":"Grigsby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCO.0b013e32832ec63f","article-title":"Role of PET in gynecologic malignancy","volume":"21","author":"Grigsby","year":"2009","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cpet.2010.07.004","article-title":"The role of FDG-PET\/CT in cervical cancer: diagnosis, staging, radiation treatment planning and follow-up","volume":"5","author":"Haynes-Outlaw","year":"2010","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cpet.2014.09.003","article-title":"PET-based radiation therapy planning","volume":"10","author":"Speirs","year":"2015","journal-title":"PET Clin"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib4","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2214\/AJR.15.14968","article-title":"Current status of hybrid PET\/MRI in oncologic imaging","volume":"206","author":"Rosenkrantz","year":"2016","journal-title":"Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cpet.2016.05.005","article-title":"The emerging role of PET\/MR imaging in gynecologic cancers","volume":"11","author":"Ponisio","year":"2016","journal-title":"PET Clin"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/j.semnuclmed.2015.03.005","article-title":"PET\/MRI evaluation of gynecologic malignancies and prostate cancer","volume":"45","author":"Bagade","year":"2015","journal-title":"Semin Nucl Med"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.007_bib7","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/OGX.0000000000000345","article-title":"Positron emission tomography\/computed tomography for gynecologic malignancies","volume":"71","author":"Oldan","year":"2016","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib8","first-page":"124","article-title":"Pitfalls in [18F]FDG PET imaging in gynecological malignancies","volume":"60","author":"Hernandez Pampaloni","year":"2016","journal-title":"Q\u00a0J Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.007_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.2967\/jnumed.115.172023","article-title":"Molecular imaging of ovarian cancer","volume":"57","author":"Sharma","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cpet.2015.05.002","article-title":"Utility of PET for radiotherapy treatment planning","volume":"10","author":"Gill","year":"2015","journal-title":"PET Clin"},{"key":"10.1016\/j.cpet.2017.11.007_bib11","unstructured":"SEER cancer stat facts: endometrial cancer. 2017. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html. Accessed April 1, 2017."},{"key":"10.1016\/j.cpet.2017.11.007_bib12","unstructured":"NCCN clinical practice guidelines in oncology: uterine neoplasms. 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/uterine.pdf. Accessed April 1, 2017."},{"issue":"9","key":"10.1016\/j.cpet.2017.11.007_bib13","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1097\/IGC.0000000000000003","article-title":"Diagnostic performance of fluorine 18 fluorodeoxyglucose positron emission tomography imaging for detection of primary lesion and staging of endometrial cancer patients: systematic review and meta-analysis of the literature","volume":"23","author":"Kakhki","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.007_bib14","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ygyno.2016.01.009","article-title":"Comparison of MRI and 18F-FDG PET\/CT in the preoperative evaluation of uterine carcinosarcoma","volume":"140","author":"Lee","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib15","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/IGC.0b013e3182a20e18","article-title":"Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature","volume":"23","author":"Sadeghi","year":"2013","journal-title":"Int J Gynecol Cancer"},{"issue":"9717","key":"10.1016\/j.cpet.2017.11.007_bib16","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"8 Suppl","key":"10.1016\/j.cpet.2017.11.007_bib17","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.cpet.2017.11.007_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/RLU.0000000000000852","article-title":"Staging of high-risk endometrial cancer with PET\/CT and sentinel lymph node mapping","volume":"40","author":"Signorelli","year":"2015","journal-title":"Clin Nucl Med"},{"issue":"9658","key":"10.1016\/j.cpet.2017.11.007_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/IGC.0000000000000393","article-title":"The role of positron emission tomography\/computed tomography in planning radiotherapy in endometrial cancer","volume":"25","author":"Simcock","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.brachy.2015.06.002","article-title":"Consensus statement for brachytherapy for the treatment of medically inoperable endometrial cancer","volume":"14","author":"Schwarz","year":"2015","journal-title":"Brachytherapy"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ygyno.2012.10.022","article-title":"Accuracy of 18-F-FDG PET imaging in the follow up of endometrial cancer patients: systematic review and meta-analysis of the literature","volume":"128","author":"Kadkhodayan","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.cpet.2017.11.007_bib25","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jacr.2013.07.017","article-title":"ACR appropriateness criteria staging and follow-up of ovarian cancer","volume":"10","author":"Mitchell","year":"2013","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.cpet.2017.11.007_bib26","unstructured":"NCCN clinical practice guidelines in oncology: ovarian cancer. 2016. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed April 1, 2017."},{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ejrad.2011.01.112","article-title":"Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis","volume":"81","author":"Yuan","year":"2012","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib28","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ygyno.2014.11.004","article-title":"Nomogram for predicting incomplete cytoreduction in advanced ovarian cancer patients","volume":"136","author":"Shim","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2001.6246","article-title":"Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy","volume":"82","author":"Rose","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","article-title":"Integrated FDG PET\/CT in patients with persistent ovarian cancer: correlation with histologic findings","volume":"233","author":"Sironi","year":"2004","journal-title":"Radiology"},{"key":"10.1016\/j.cpet.2017.11.007_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bpobgyn.2016.11.005","article-title":"Role of radiation therapy","volume":"41","author":"Eifel","year":"2017","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.1988.6.8.1254","article-title":"Early stage ovarian cancer: a randomized clinical trial comparing whole abdominal radiotherapy, melphalan, and intraperitoneal chromic phosphate: a National Cancer Institute of Canada Clinical Trials Group report","volume":"6","author":"Klaassen","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0360-3016(91)90743-N","article-title":"Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma","volume":"21","author":"Eifel","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.007_bib35","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1200\/JCO.1988.6.9.1433","article-title":"Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy","volume":"6","author":"Schray","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib36","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/annonc\/mdq383","article-title":"Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers","volume":"22","author":"Swenerton","year":"2011","journal-title":"Ann Oncol"},{"issue":"14","key":"10.1016\/j.cpet.2017.11.007_bib37","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.2011.40.1646","article-title":"Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation","volume":"30","author":"Hoskins","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2013.04.469","article-title":"Involved-field radiation therapy for locoregionally recurrent ovarian cancer","volume":"130","author":"Brown","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib39","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2016.02.005","article-title":"Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy","volume":"141","author":"Chundury","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET\u2013CT, CT and MRI in diagnosing recurrent ovarian carcinoma","volume":"71","author":"Gu","year":"2009","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib41","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/IGC.0b013e31828a183c","article-title":"Accuracy of positron emission tomography\/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis","volume":"23","author":"Limei","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.cpet.2017.11.007_bib42","unstructured":"SEER cancer stat facts: cervical cancer. 2017. Available at: https:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Accessed April 1, 2017."},{"key":"10.1016\/j.cpet.2017.11.007_bib43","unstructured":"NCCN clinical practice guidelines in oncology: cervical cancer. 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf. Accessed April 1, 2017."},{"issue":"6","key":"10.1016\/j.cpet.2017.11.007_bib44","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacr.2012.02.021","article-title":"ACR appropriateness criteria\u00ae pretreatment planning of invasive cancer of the cervix","volume":"9","author":"Siegel","year":"2012","journal-title":"J\u00a0Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib45","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2005.10.005","article-title":"F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy","volume":"101","author":"Xue","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib46","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/cncr.22974","article-title":"The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival","volume":"110","author":"Kidd","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0360-3016(02)02705-0","article-title":"Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy","volume":"53","author":"Miller","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"16","key":"10.1016\/j.cpet.2017.11.007_bib48","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/1078-0432.CCR-07-5252","article-title":"Intratumoral metabolic heterogeneity of cervical cancer","volume":"14","author":"Kidd","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib49","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/IGC.0b013e3181b62e8c","article-title":"18F-fluorodeoxyglucose-positron emission tomography and pathologic tumor size in early-stage invasive cervical cancer","volume":"19","author":"Showalter","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib50","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jmri.23830","article-title":"Tumor volume and subvolume concordance between FDG-PET\/CT and diffusion-weighted MRI for squamous cell carcinoma of the cervix","volume":"37","author":"Olsen","year":"2013","journal-title":"J\u00a0Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2017.11.007_bib51","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1503\/cmaj.071124","article-title":"Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis","volume":"178","author":"Selman","year":"2008","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.007_bib52","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1349-7006.2010.01532.x","article-title":"Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis","volume":"101","author":"Choi","year":"2010","journal-title":"Cancer Sci"},{"issue":"17","key":"10.1016\/j.cpet.2017.11.007_bib53","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1200\/JCO.2001.19.17.3745","article-title":"Lymph node staging by positron emission tomography in patients with carcinoma of the cervix","volume":"19","author":"Grigsby","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.cpet.2017.11.007_bib54","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1200\/JCO.2009.25.4151","article-title":"Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis","volume":"28","author":"Kidd","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.007_bib55","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/cncr.24972","article-title":"Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer","volume":"116","author":"Kidd","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ygyno.2012.06.027","article-title":"FDG-PET-based prognostic nomograms for locally advanced cervical cancer","volume":"127","author":"Kidd","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage\u00a0IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.cpet.2017.11.007_bib58","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.cpet.2017.11.007_bib59","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM199904153401501","article-title":"Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer","volume":"340","author":"Morris","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"9077","key":"10.1016\/j.cpet.2017.11.007_bib60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(97)02250-2","article-title":"Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer","volume":"350","author":"Landoni","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib61","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2008.02.014","article-title":"Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer","volume":"71","author":"Macdonald","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib62","first-page":"5736","article-title":"Clinical implementation of multisequence MRI-based adaptive intracavitary brachytherapy for cervix cancer","volume":"17","author":"Zoberi","year":"2016","journal-title":"J\u00a0Appl Clin Med Phys"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib63","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ijrobp.2008.02.063","article-title":"Prospective clinical trial of positron emission tomography\/computed tomography image-guided intensity-modulated radiation therapy for cervical carcinoma with positive para-aortic lymph nodes","volume":"72","author":"Esthappan","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib64","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2009.06.041","article-title":"Clinical outcomes of definitive intensity-modulated radiation therapy with fluorodeoxyglucose\u2013positron emission tomography simulation in patients with locally advanced cervical cancer","volume":"77","author":"Kidd","year":"2010","journal-title":"Int J Radiat Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib65","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2012.02.056","article-title":"Changes in cervical cancer FDG uptake during chemoradiation and association with response","volume":"85","author":"Kidd","year":"2013","journal-title":"Int J Radiat Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib66","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2008.03.040","article-title":"18-F-fluorodeoxyglucose\u2013positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer","volume":"72","author":"Schwarz","year":"2008","journal-title":"Int J Radiat Oncol"},{"issue":"19","key":"10.1016\/j.cpet.2017.11.007_bib67","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib68","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MNM.0000000000000026","article-title":"Diagnostic value of 18F-FDG-PET or PET-CT in recurrent cervical cancer","volume":"35","author":"Chu","year":"2014","journal-title":"Nucl Med Commun"},{"issue":"9","key":"10.1016\/j.cpet.2017.11.007_bib69","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s10552-009-9418-8","article-title":"Is the incidence of invasive vulvar cancer increasing in the United States?","volume":"20","author":"Bodelon","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.cpet.2017.11.007_bib70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/gyno.2002.6605","article-title":"Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer","volume":"85","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib71","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00330-014-3530-1","article-title":"Computed tomography, magnetic resonance imaging and FDG positron emission tomography in the management of vulvar malignancies","volume":"25","author":"Lin","year":"2015","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.007_bib72","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.01.011","article-title":"The impact of FDG-PET\/CT in the management of patients with vulvar and vaginal cancer","volume":"140","author":"Robertson","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cpet.2017.11.007_bib73","unstructured":"NCCN clinical practice guidelines in oncology: vulvar cancer. 2017. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/vulvar.pdf. Accessed April 1, 2017."},{"issue":"3","key":"10.1016\/j.cpet.2017.11.007_bib74","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0090-8258(90)90064-R","article-title":"Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva","volume":"38","author":"Heaps","year":"1990","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib75","article-title":"Chemoradiation for advanced primary vulval cancer","author":"Shylasree","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib76","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.cpet.2017.11.007_bib77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.adro.2017.02.006","article-title":"Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes","volume":"2","author":"Rao","year":"2017","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.cpet.2017.11.007_bib78","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/COC.0b013e318295af1d","article-title":"ACR appropriateness criteria\u00ae management of locoregionally advanced squamous cell carcinoma of the vulva","volume":"36","author":"Kidd","year":"2013","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.007_bib79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.radonc.2016.12.019","article-title":"Association of post-treatment positron emission tomography with locoregional control and survival after radiation therapy for squamous cell carcinoma of the vulva","volume":"122","author":"Rao","year":"2017","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.cpet.2017.11.007_bib80","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/AOG.0b013e31819fe844","article-title":"Factors affecting risk of mortality in women with vaginal cancer","volume":"113","author":"Shah","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cpet.2017.11.007_bib81","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2004.12.011","article-title":"FDG-PET evaluation of vaginal carcinoma","volume":"62","author":"Lamoreaux","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.cpet.2017.11.007_bib82","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am J Obstet Gynecol"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685981730130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155685981730130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T21:25:24Z","timestamp":1535059524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155685981730130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S155685981730130X"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2017.11.007","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of PET Imaging in Gynecologic Radiation Oncology","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}